NCT02262780View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2003

Primary Completion Date

February 15, 2004

Conditions
Healthy
Interventions
DRUG

Low dose of telmisartan

DRUG

High dose of telmisartan

DRUG

HCTZ

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY